MultiPlan Reports First Quarter 2024 Results
![(NYSE:MPLN) MultiPlan Announces](https://www.multiplan.us/wp-content/uploads/2021/06/Press-release-image-A.png)
– Q1 2024 Revenues of $234.5 million, Net Loss of $539.7 million (including a $519.1 million impairment of goodwill and indefinite-lived intangible assets), and Adjusted EBITDA of $146.8 million – Identified potential medical cost savings of approximately $5.7 billion in Q1 2024, up 3% from Q1 2023 and down 3% from Q4 2023 – Repurchased […]